CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant
Clinical trial NCT06687772 · RECRUITING
Trial details
- NCT number
- NCT06687772
- Sponsor
- Washington University School of Medicine
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-16
- Primary completion
- 2027-07-31
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.